Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Environ Res. 2014 Aug 29;134:233–241. doi: 10.1016/j.envres.2014.08.010

Table 2.

Percent change in ln-transformed hormone per IQR increase in urinary phthalate metabolite or BPA, adjusted for age, BMI Z-score, and specific gravity

In utero Measures of Urinary BPA and Phthalate Metabolites (n=115)
ln Estradiol ln Testosterone ln SHBG ln DHEA-S ln Inhibin B
% Change 95%CI p-value % Change 95%CI p-value % Change 95%CI p-value % Change 95%CI p-value % Change 95%CI p-value





ln MEHP 10.0 −4.5, 26.6 0.19 −7.2 −28.1, 19.9 0.57 −5.4 −15.7, 6.0 0.33 29.1 9.2, 52.6 0.003 22.5 0.9, 48.7 0.04
ln MEHHP 8.3 −6.1, 24.9 0.27 3.3 −20.2, 33.8 0.80 −3.2 −13.8, 8.7 0.58 19.2 0.3, 41.6 0.05 17.3 −3.7, 42.8 0.11
ln MEOHP 8.6 −6.4, 25.9 0.28 4.6 −20.1, 36.9 0.74 −4.8 −15.6, 7.4 0.42 23.5 3.3, 47.6 0.02 18.4 −3.6, 45.3 0.11
ln MECPP 11.8 −3.4, 29.3 0.13 0.4 −23.0, 30.9 0.98 −4.5 −15.1, 7.5 0.44 24.1 4.2, 47.9 0.02 22.5 0.3, 49.7 0.05
ln MBzP −2.7 −13.8, 9.7 0.65 28.9 4.3, 59.3 0.02 −1.7 −10.8, 8.4 0.73 0.0 −13.7, 15.9 1.00 0.4 −15.1, 18.6 0.97
ln MnBP 0.6 −12.0, 15.0 0.93 12.4 −11.6, 42.8 0.34 −1.4 −11.4, 9.9 0.80 18.8 1.2, 39.4 0.04 −1.7 −18.4, 18.3 0.85
ln MiBP 6.9 −7.0, 23.0 0.34 17.4 −8.6, 50.8 0.21 −0.4 −11.0, 11.5 0.95 19.5 1.0, 41.3 0.04 4.5 −13.9, 26.9 0.65
ln MCPP 3.6 −11.0, 20.6 0.65 7.0 −18.6, 40.7 0.62 −3.2 −14.4, 9.4 0.60 21.5 1.2, 45.8 0.04 12.1 −9.1, 38.3 0.28
ln MEP 1.1 −10.0, 13.6 0.85 25.5 2.1, 54.1 0.03 −4.1 −12.6, 5.4 0.38 10.8 −3.8, 27.6 0.15 7.9 −8.1, 26.8 0.35
ln BPA −4.4 −26.0, 23.5 0.73 2.0 −35.7, 61.8 0.93 −7.1 −24.4, 14.2 0.48 20.9 −11.4, 65.1 0.23 6.5 −25.3, 52.0 0.72
Peripubertal Measures of Urinary BPA and Phthalate Metabolites (n=128)
ln Estradiol ln Testosterone ln SHBG ln DHEA-S ln Inhibin B
% Change 95%CI p-value % Change 95%CI p-value % Change 95%CI p-value % Change 95%CI p-value % Change 95%CI p-value





ln MEHP −0.3 −13.3, 14.6 0.96 −4.1 −24.2, 21.4 0.73 2.7 −8.4, 15.3 0.64 −1.8 −16.6, 15.7 0.83 −0.7 −18.3, 20.7 0.94
ln MEHHP 4.5 −10.9, 22.5 0.59 4.8 −19.9, 37.2 0.73 2.6 −10.1, 17.0 0.70 −11.2 −26.3, 6.9 0.21 2.4 −18.1, 28.0 0.83
ln MEOHP 6.2 −8.7, 23.6 0.43 5.0 −18.7, 35.5 0.71 4.3 −7.9, 18.2 0.50 −10.1 −24.6, 7.3 0.24 8.6 −12.1, 34.2 0.44
ln MECPP 5.9 −8.7, 22.9 0.45 −10.0 −30.0, 15.7 0.41 3.6 −8.4, 17.1 0.57 −11.9 −25.9, 4.8 0.15 1.6 −17.5, 25.2 0.88
ln MBzP 3.3 −9.8, 18.2 0.64 15.7 −7.8, 45.2 0.21 14.4 2.6, 27.6 0.02 −10.6 −23.6, 4.7 0.16 1.4 −16.1, 22.5 0.89
ln MnBP 2.6 −10.5, 17.7 0.71 0.8 −20.0, 26.9 0.95 4.2 −6.9, 16.7 0.47 −3.3 −17.7, 13.5 0.68 −7.7 −23.7, 11.8 0.41
ln MiBP 14.2 −1.3, 32.2 0.07 7.5 −16.2, 37.9 0.57 4.9 −7.1, 18.5 0.44 −2.2 −17.7, 16.4 0.80 −2.7 −20.9, 19.7 0.79
ln MCPP −2.5 −15.0, 11.8 0.71 −10.1 −28.6, 13.2 0.36 9.2 −2.3, 22.1 0.12 −7.2 −20.9, 8.9 0.36 −7.0 −23.2, 12.6 0.45
ln MEP −3.8 −16.0, 10.1 0.57 17.0 −6.6, 46.7 0.17 3.8 −7.1, 16.0 0.50 −8.8 −22.1, 6.8 0.25 −14.0 −28.6, 3.7 0.11
ln BPA −5.0 −19.6, 12.2 0.54 10.7 −16.4, 46.7 0.47 −3.2 −15.6, 11.1 0.65 −1.9 −19.3, 19.3 0.85 15.9 −8.1, 46.2 0.21

CI, confidence interval